Diabetes mellitus and prostate cancer metabolism: Is there a relationship?

Detalhes bibliográficos
Autor(a) principal: Antunes, Hugo Pontes
Data de Publicação: 2018
Outros Autores: Teixo, Ricardo, Carvalho, João André, Eliseu, Miguel, Marques, Inês, Mamede, Ana, Neves, Rita, Oliveira, Rui, Silva, Edgar Tavares da, Parada, Belmiro, Abrantes, Ana M., Figueiredo, Arnaldo, Botelho, Maria Filomena
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10316/107500
https://doi.org/10.4081/aiua.2018.3.184
Resumo: Objective: Our aim was to evaluate the effects of glucose levels and diabetes mellitus in prostate cancer (PCa) biology. Materials and methods: Two PCa cell lines (LNCap and PC3) were cultured in RPMI medium with different glucose concentrations [5mM (LG) and 25mM (HG)]. Expressions of androgen receptor, Her2/neu and glucose transporters (GLUT1, 3, 5 and 12) were evaluated by flow cytometry. Proliferation rate was assessed by colorimetric assay MTT and cellular characterization was performed by haematoxylin and eosin staining. Additionally, we performed a cross sectional analysis of 704 patients undergoing radical prostatectomy who were divided into two groups (diabetic and non-diabetic). An analysis of clinical and histological data seeking to identify the differences on tumor aggressiveness between the two groups was performed. Results: In LNCaP cell line, when the glucose concentration in the medium increased, there was an increased in AR expression. Regarding expression of Her2/neu receptor, medium’s glucose concentration significantly changed the expression of this receptor in both PC3 and LNCaP cell lines. Growth rate was higher on the HG medium for both cell lines. The clinical study of patients undergoing radical prostatectomy revealed no relationship between the presence of diabetes and the development of more aggressive tumours. Diabetic patients had significantly higher prostatic volumes, however, no significant difference was found between the relapse risk classification or the ISUP classification between the two groups. Conclusions: Our results showed that medium glucose concentration could influence prostate cancer cells growing but not the aggressiveness.
id RCAP_89893d5e6107ba53517acd02ce11ef1e
oai_identifier_str oai:estudogeral.uc.pt:10316/107500
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Diabetes mellitus and prostate cancer metabolism: Is there a relationship?DiabetesGlucoseProstate cancerHormonal receptors18F-FDG.AgedBlood GlucoseCell Line, TumorCell ProliferationCross-Sectional StudiesDiabetes MellitusFlow CytometryHumansMaleMiddle AgedPC-3 CellsProstatectomyProstatic NeoplasmsReceptor, ErbB-2Receptors, AndrogenObjective: Our aim was to evaluate the effects of glucose levels and diabetes mellitus in prostate cancer (PCa) biology. Materials and methods: Two PCa cell lines (LNCap and PC3) were cultured in RPMI medium with different glucose concentrations [5mM (LG) and 25mM (HG)]. Expressions of androgen receptor, Her2/neu and glucose transporters (GLUT1, 3, 5 and 12) were evaluated by flow cytometry. Proliferation rate was assessed by colorimetric assay MTT and cellular characterization was performed by haematoxylin and eosin staining. Additionally, we performed a cross sectional analysis of 704 patients undergoing radical prostatectomy who were divided into two groups (diabetic and non-diabetic). An analysis of clinical and histological data seeking to identify the differences on tumor aggressiveness between the two groups was performed. Results: In LNCaP cell line, when the glucose concentration in the medium increased, there was an increased in AR expression. Regarding expression of Her2/neu receptor, medium’s glucose concentration significantly changed the expression of this receptor in both PC3 and LNCaP cell lines. Growth rate was higher on the HG medium for both cell lines. The clinical study of patients undergoing radical prostatectomy revealed no relationship between the presence of diabetes and the development of more aggressive tumours. Diabetic patients had significantly higher prostatic volumes, however, no significant difference was found between the relapse risk classification or the ISUP classification between the two groups. Conclusions: Our results showed that medium glucose concentration could influence prostate cancer cells growing but not the aggressiveness.Istituto di Urologia2018-09-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/107500http://hdl.handle.net/10316/107500https://doi.org/10.4081/aiua.2018.3.184eng1124-3562Antunes, Hugo PontesTeixo, RicardoCarvalho, João AndréEliseu, MiguelMarques, InêsMamede, AnaNeves, RitaOliveira, RuiSilva, Edgar Tavares daParada, BelmiroAbrantes, Ana M.Figueiredo, ArnaldoBotelho, Maria Filomenainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-17T10:04:51Zoai:estudogeral.uc.pt:10316/107500Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:23:50.881765Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Diabetes mellitus and prostate cancer metabolism: Is there a relationship?
title Diabetes mellitus and prostate cancer metabolism: Is there a relationship?
spellingShingle Diabetes mellitus and prostate cancer metabolism: Is there a relationship?
Antunes, Hugo Pontes
Diabetes
Glucose
Prostate cancer
Hormonal receptors
18F-FDG.
Aged
Blood Glucose
Cell Line, Tumor
Cell Proliferation
Cross-Sectional Studies
Diabetes Mellitus
Flow Cytometry
Humans
Male
Middle Aged
PC-3 Cells
Prostatectomy
Prostatic Neoplasms
Receptor, ErbB-2
Receptors, Androgen
title_short Diabetes mellitus and prostate cancer metabolism: Is there a relationship?
title_full Diabetes mellitus and prostate cancer metabolism: Is there a relationship?
title_fullStr Diabetes mellitus and prostate cancer metabolism: Is there a relationship?
title_full_unstemmed Diabetes mellitus and prostate cancer metabolism: Is there a relationship?
title_sort Diabetes mellitus and prostate cancer metabolism: Is there a relationship?
author Antunes, Hugo Pontes
author_facet Antunes, Hugo Pontes
Teixo, Ricardo
Carvalho, João André
Eliseu, Miguel
Marques, Inês
Mamede, Ana
Neves, Rita
Oliveira, Rui
Silva, Edgar Tavares da
Parada, Belmiro
Abrantes, Ana M.
Figueiredo, Arnaldo
Botelho, Maria Filomena
author_role author
author2 Teixo, Ricardo
Carvalho, João André
Eliseu, Miguel
Marques, Inês
Mamede, Ana
Neves, Rita
Oliveira, Rui
Silva, Edgar Tavares da
Parada, Belmiro
Abrantes, Ana M.
Figueiredo, Arnaldo
Botelho, Maria Filomena
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Antunes, Hugo Pontes
Teixo, Ricardo
Carvalho, João André
Eliseu, Miguel
Marques, Inês
Mamede, Ana
Neves, Rita
Oliveira, Rui
Silva, Edgar Tavares da
Parada, Belmiro
Abrantes, Ana M.
Figueiredo, Arnaldo
Botelho, Maria Filomena
dc.subject.por.fl_str_mv Diabetes
Glucose
Prostate cancer
Hormonal receptors
18F-FDG.
Aged
Blood Glucose
Cell Line, Tumor
Cell Proliferation
Cross-Sectional Studies
Diabetes Mellitus
Flow Cytometry
Humans
Male
Middle Aged
PC-3 Cells
Prostatectomy
Prostatic Neoplasms
Receptor, ErbB-2
Receptors, Androgen
topic Diabetes
Glucose
Prostate cancer
Hormonal receptors
18F-FDG.
Aged
Blood Glucose
Cell Line, Tumor
Cell Proliferation
Cross-Sectional Studies
Diabetes Mellitus
Flow Cytometry
Humans
Male
Middle Aged
PC-3 Cells
Prostatectomy
Prostatic Neoplasms
Receptor, ErbB-2
Receptors, Androgen
description Objective: Our aim was to evaluate the effects of glucose levels and diabetes mellitus in prostate cancer (PCa) biology. Materials and methods: Two PCa cell lines (LNCap and PC3) were cultured in RPMI medium with different glucose concentrations [5mM (LG) and 25mM (HG)]. Expressions of androgen receptor, Her2/neu and glucose transporters (GLUT1, 3, 5 and 12) were evaluated by flow cytometry. Proliferation rate was assessed by colorimetric assay MTT and cellular characterization was performed by haematoxylin and eosin staining. Additionally, we performed a cross sectional analysis of 704 patients undergoing radical prostatectomy who were divided into two groups (diabetic and non-diabetic). An analysis of clinical and histological data seeking to identify the differences on tumor aggressiveness between the two groups was performed. Results: In LNCaP cell line, when the glucose concentration in the medium increased, there was an increased in AR expression. Regarding expression of Her2/neu receptor, medium’s glucose concentration significantly changed the expression of this receptor in both PC3 and LNCaP cell lines. Growth rate was higher on the HG medium for both cell lines. The clinical study of patients undergoing radical prostatectomy revealed no relationship between the presence of diabetes and the development of more aggressive tumours. Diabetic patients had significantly higher prostatic volumes, however, no significant difference was found between the relapse risk classification or the ISUP classification between the two groups. Conclusions: Our results showed that medium glucose concentration could influence prostate cancer cells growing but not the aggressiveness.
publishDate 2018
dc.date.none.fl_str_mv 2018-09-30
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10316/107500
http://hdl.handle.net/10316/107500
https://doi.org/10.4081/aiua.2018.3.184
url http://hdl.handle.net/10316/107500
https://doi.org/10.4081/aiua.2018.3.184
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1124-3562
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Istituto di Urologia
publisher.none.fl_str_mv Istituto di Urologia
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134124519194625